Cargando…
Efficacy and safety of potent P2Y12 inhibitors vs. clopidogrel in elderly patients with acute coronary syndrome
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722603/ https://www.ncbi.nlm.nih.gov/pubmed/32991367 http://dx.doi.org/10.1097/CM9.0000000000001119 |
| _version_ | 1783620185945538560 |
|---|---|
| author | Luo, Li-Man Pang, Zhan-Qi Fu, Meng-Lu Li, Yuan-Yuan Tu, Ling Xu, Xi-Zhen |
| author_facet | Luo, Li-Man Pang, Zhan-Qi Fu, Meng-Lu Li, Yuan-Yuan Tu, Ling Xu, Xi-Zhen |
| author_sort | Luo, Li-Man |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7722603 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77226032020-12-08 Efficacy and safety of potent P2Y12 inhibitors vs. clopidogrel in elderly patients with acute coronary syndrome Luo, Li-Man Pang, Zhan-Qi Fu, Meng-Lu Li, Yuan-Yuan Tu, Ling Xu, Xi-Zhen Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2020-11-05 2020-09-24 /pmc/articles/PMC7722603/ /pubmed/32991367 http://dx.doi.org/10.1097/CM9.0000000000001119 Text en Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
| spellingShingle | Correspondence Luo, Li-Man Pang, Zhan-Qi Fu, Meng-Lu Li, Yuan-Yuan Tu, Ling Xu, Xi-Zhen Efficacy and safety of potent P2Y12 inhibitors vs. clopidogrel in elderly patients with acute coronary syndrome |
| title | Efficacy and safety of potent P2Y12 inhibitors vs. clopidogrel in elderly patients with acute coronary syndrome |
| title_full | Efficacy and safety of potent P2Y12 inhibitors vs. clopidogrel in elderly patients with acute coronary syndrome |
| title_fullStr | Efficacy and safety of potent P2Y12 inhibitors vs. clopidogrel in elderly patients with acute coronary syndrome |
| title_full_unstemmed | Efficacy and safety of potent P2Y12 inhibitors vs. clopidogrel in elderly patients with acute coronary syndrome |
| title_short | Efficacy and safety of potent P2Y12 inhibitors vs. clopidogrel in elderly patients with acute coronary syndrome |
| title_sort | efficacy and safety of potent p2y12 inhibitors vs. clopidogrel in elderly patients with acute coronary syndrome |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722603/ https://www.ncbi.nlm.nih.gov/pubmed/32991367 http://dx.doi.org/10.1097/CM9.0000000000001119 |
| work_keys_str_mv | AT luoliman efficacyandsafetyofpotentp2y12inhibitorsvsclopidogrelinelderlypatientswithacutecoronarysyndrome AT pangzhanqi efficacyandsafetyofpotentp2y12inhibitorsvsclopidogrelinelderlypatientswithacutecoronarysyndrome AT fumenglu efficacyandsafetyofpotentp2y12inhibitorsvsclopidogrelinelderlypatientswithacutecoronarysyndrome AT liyuanyuan efficacyandsafetyofpotentp2y12inhibitorsvsclopidogrelinelderlypatientswithacutecoronarysyndrome AT tuling efficacyandsafetyofpotentp2y12inhibitorsvsclopidogrelinelderlypatientswithacutecoronarysyndrome AT xuxizhen efficacyandsafetyofpotentp2y12inhibitorsvsclopidogrelinelderlypatientswithacutecoronarysyndrome |